Christopher Causey's most recent trade in United Therapeutics Corp was a trade of 1,000 Common Stock done at an average price of $440 . Disclosure was reported to the exchange on Sept. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 440.00 per share. | 24 Sep 2025 | 1,000 | 4,865 (0%) | 0% | 440 | 440,000 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2025 | 1,000 | 9,320 | - | - | Stock Option | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 119.76 per share. | 24 Sep 2025 | 1,000 | 5,865 (0%) | 0% | 119.8 | 119,760 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.30 per share. | 02 Sep 2025 | 3,000 | 7,865 (0%) | 0% | 132.3 | 396,900 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 3,000 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 430.00 per share. | 02 Sep 2025 | 1,000 | 5,865 (0%) | 0% | 430 | 430,000 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 419.63 per share. | 02 Sep 2025 | 1,000 | 6,865 (0%) | 0% | 419.6 | 419,630 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 420.00 per share. | 02 Sep 2025 | 1,000 | 4,865 (0%) | 0% | 420 | 420,000 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 3,650 | 3,650 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2025 | 1,190 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2025 | 1,190 | 4,865 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 376.63 per share. | 01 Nov 2024 | 510 | 3,675 (0%) | 0% | 376.6 | 192,080 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 349.00 per share. | 21 Aug 2024 | 1,210 | 4,185 (0%) | 0% | 349 | 422,290 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2024 | 1,210 | 3,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 132.30 per share. | 21 Aug 2024 | 1,210 | 5,395 (0%) | 0% | 132.3 | 160,083 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 1,190 | 1,190 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2024 | 3,000 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 112.14 per share. | 18 Jun 2024 | 3,000 | 7,185 (0%) | 0% | 112.1 | 336,420 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 304.18 per share. | 18 Jun 2024 | 3,000 | 4,185 (0%) | 0% | 304.2 | 912,539 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 2,000 | 3,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 281.53 per share. | 13 Jun 2024 | 2,000 | 4,185 (0%) | 0% | 281.5 | 563,055 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 112.14 per share. | 13 Jun 2024 | 2,000 | 6,185 (0%) | 0% | 112.1 | 224,280 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,000 | 5,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 112.14 per share. | 15 May 2024 | 2,000 | 6,185 (0%) | 0% | 112.1 | 224,280 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 272.90 per share. | 15 May 2024 | 2,000 | 4,185 (0%) | 0% | 272.9 | 545,800 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 2,240 | 7,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 259.91 per share. | 03 May 2024 | 2,240 | 4,185 (0%) | 0% | 259.9 | 582,195 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 112.14 per share. | 03 May 2024 | 2,240 | 6,425 (0%) | 0% | 112.1 | 251,194 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 255.00 per share. | 15 Dec 2023 | 400 | 4,185 (0%) | 0% | 255 | 102,000 | Common Stock |
| United Therapeutics Corp | Causey Christopher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 3,000 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 12 Dec 2023 | 3,000 | 7,585 (0%) | 0% | 175.4 | 526,290 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 249.68 per share. | 12 Dec 2023 | 3,000 | 4,585 (0%) | 0% | 249.7 | 749,034 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 4,560 | 4,560 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 1,750 | 0 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 1,750 | 4,585 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 1,000 | 3,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 03 Jan 2023 | 1,000 | 3,835 (0%) | 0% | 175.4 | 175,430 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 276.26 per share. | 03 Jan 2023 | 1,000 | 2,835 (0%) | 0% | 276.3 | 276,260 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2022 | 2,500 | 9,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2022 | 2,500 | 4,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2022 | 2,500 | 6,500 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 02 Nov 2022 | 2,500 | 2,835 (0%) | 0% | 260 | 650,000 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 02 Nov 2022 | 2,500 | 5,335 (0%) | 0% | 175.4 | 438,575 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 250.01 per share. | 02 Nov 2022 | 2,500 | 2,835 (0%) | 0% | 250.0 | 625,024 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 02 Nov 2022 | 2,500 | 5,335 (0%) | 0% | 175.4 | 438,575 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 240.00 per share. | 02 Nov 2022 | 2,500 | 2,835 (0%) | 0% | 240 | 600,000 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 02 Nov 2022 | 2,500 | 5,335 (0%) | 0% | 175.4 | 438,575 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 224.96 per share. | 23 Aug 2022 | 3,500 | 2,835 (0%) | 0% | 225.0 | 787,360 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2022 | 3,500 | 11,500 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 175.43 per share. | 23 Aug 2022 | 3,500 | 6,335 (0%) | 0% | 175.4 | 614,005 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 2,160 | 2,835 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2022 | 2,160 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Christopher Causey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 1,750 | 1,750 | - | - | Restricted Stock Unit | |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 236.79 per share. | 27 Jun 2022 | 5,000 | 675 (0%) | 0% | 236.8 | 1,183,950 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2022 | 5,000 | 0 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.36 per share. | 27 Jun 2022 | 5,000 | 5,675 (0%) | 0% | 76.4 | 381,800 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 May 2022 | 75 | 675 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 5,000 | 5,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.36 per share. | 26 May 2022 | 5,000 | 5,750 (0%) | 0% | 76.4 | 381,800 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 222.96 per share. | 26 May 2022 | 2,600 | 2,450 (0%) | 0% | 223.0 | 579,684 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 224.10 per share. | 26 May 2022 | 983 | 1,467 (0%) | 0% | 224.1 | 220,290 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 221.65 per share. | 26 May 2022 | 700 | 5,050 (0%) | 0% | 221.7 | 155,157 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 226.72 per share. | 26 May 2022 | 350 | 950 (0%) | 0% | 226.7 | 79,353 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 227.44 per share. | 26 May 2022 | 200 | 750 (0%) | 0% | 227.4 | 45,488 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 226.06 per share. | 26 May 2022 | 167 | 1,300 (0%) | 0% | 226.1 | 37,752 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 76.36 per share. | 06 Aug 2021 | 2,610 | 3,360 (0%) | 0% | 76.4 | 199,300 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 2,610 | 10,000 | - | - | Stock Options | |
| United Therapeutics Corp | Christopher Causey | Director | Sale of securities on an exchange or to another person at price $ 210.00 per share. | 06 Aug 2021 | 2,610 | 750 (0%) | 0% | 210 | 548,100 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 2,160 | 2,160 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Christopher Causey | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 May 2021 | 75 | 750 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 15 Jan 2021 | 1,500 | 2,325 (0%) | 0% | 88.0 | 132,045 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 172.82 per share. | 15 Jan 2021 | 1,500 | 825 (0%) | 0% | 172.8 | 259,230 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 1,500 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 06 Jan 2021 | 1,500 | 2,325 (0%) | 0% | 88.0 | 132,045 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 1,500 | 1,500 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 1,500 | 3,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 167.05 per share. | 06 Jan 2021 | 1,500 | 825 (0%) | 0% | 167.1 | 250,575 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 06 Jan 2021 | 1,500 | 2,325 (0%) | 0% | 88.0 | 132,045 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 163.51 per share. | 06 Jan 2021 | 1,500 | 825 (0%) | 0% | 163.5 | 245,265 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2021 | 1,500 | 4,500 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 05 Jan 2021 | 1,500 | 2,325 (0%) | 0% | 88.0 | 132,045 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 156.77 per share. | 05 Jan 2021 | 1,500 | 825 (0%) | 0% | 156.8 | 235,155 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.03 per share. | 23 Dec 2020 | 1,500 | 2,325 (0%) | 0% | 88.0 | 132,045 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2020 | 1,500 | 13,500 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 149.36 per share. | 23 Dec 2020 | 1,500 | 825 (0%) | 0% | 149.4 | 224,040 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2020 | 2,000 | 0 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 28 Oct 2020 | 2,000 | 2,825 (0%) | 0% | 63.9 | 127,800 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 132.03 per share. | 28 Oct 2020 | 2,000 | 825 (0%) | 0% | 132.0 | 264,060 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 122.10 per share. | 22 Oct 2020 | 2,500 | 825 (0%) | 0% | 122.1 | 305,250 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2020 | 2,500 | 2,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 22 Oct 2020 | 2,500 | 3,325 (0%) | 0% | 63.9 | 159,750 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 16 Oct 2020 | 1,500 | 2,325 (0%) | 0% | 63.9 | 95,850 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 115.00 per share. | 16 Oct 2020 | 1,500 | 825 (0%) | 0% | 115 | 172,500 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2020 | 1,500 | 4,500 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2020 | 750 | 6,000 | - | - | Share Tracking Award | |
| United Therapeutics Corp | Christopher Causey | Director | Sale or transfer of securities back to the company at price $ 115.00 per share. | 16 Oct 2020 | 750 | 825 (0%) | 0% | 115 | 86,250 | Common Stock |
| United Therapeutics Corp | Christopher Causey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 16 Oct 2020 | 750 | 1,575 (0%) | 0% | 63.9 | 47,925 | Common Stock |